Intellia Therapeutics Inc buy Bank of America Co.
Start price
27.10.25
/
50%
€12.81
Target price
27.10.26
€25.78
Performance (%)
-8.98%
Price
27.02.26
€11.66
Summary
This prediction is currently active. With a performance of -8.98%, the BUY prediction for Intellia Therapeutics Inc by Bank_of_America_Co_ is down slightly. This prediction currently runs until 27.10.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 8.566% | 8.566% |
| iShares Core DAX® | -0.383% | 1.093% |
| iShares Nasdaq 100 | -0.411% | -1.973% |
| iShares Nikkei 225® | 1.838% | 10.261% |
| iShares S&P 500 | -0.712% | 0.445% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NASDAQ:NTLA) had its price target lowered by analysts at Bank of America Corporation from $36.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat